ConductScience.org, home

Trial · NCT07887581

Coping and Adaptation for Recovery From Moral Injury: A Group Intervention for Clinical Psychology Residents

NCT07887581, Not applicable, Not yet recruiting, Universidad Complutense de Madrid

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. Coping and Adaptation for Recovery From Moral Injury: A Group Intervention for Clinical Psychology Residents. Trials, record NCT07887581. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07887581

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Coping and Adaptation for Recovery From Moral Injury: A Group Intervention for Clinical Psychology Residents
NCT number
NCT07887581
Status
Not yet recruiting
Phases
Not applicable
Enrollment
10 participants, estimated
Lead sponsor
Universidad Complutense de Madrid
Conditions
Moral Distress, Moral Injury
Interventions
CARE-MI Group Intervention
First posted
2026-10-21
Last updated
2026-10-21

Source ClinicalTrials.gov

Registered outcomes6

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryChange in Moral Injury Assessed With the Health Care Moral Injury ScaleBaseline and Week 4 (immediately after completion of the four-session intervention).
Moral injury will be assessed using the 10-item Health Care Moral Injury Scale (HMIS). Each item is rated on a 5-point Likert scale from 1 (strongly disagree) to 5 (strongly agree). Item scores are summed to produce a total score ranging from 10 to 50, with higher scores indicating greater moral injury. The outcome will be the change in total HMIS score from baseline to post-intervention.
SecondaryChange in Mental Well-Being Assessed With the Warwick-Edinburgh Mental Well-Being ScaleBaseline and Week 4 (immediately after completion of the four-session intervention).
Mental well-being will be assessed using the 14-item Warwick-Edinburgh Mental Well-Being Scale (WEMWBS). Each item is rated from 1 to 5. Item scores are summed to produce a total score ranging from 14 to 70, with higher scores indicating greater mental well-being. The outcome will be the change in total WEMWBS score from baseline to post-intervention.
SecondaryChange in Depressive Symptoms Assessed With the Patient Health Questionnaire-9Baseline and Week 4 (immediately after completion of the four-session intervention).
Depressive symptoms will be assessed using the 9-item Patient Health Questionnaire (PHQ-9). Each item is rated from 0 to 3. Item scores are summed to produce a total score ranging from 0 to 27, with higher scores indicating greater severity of depressive symptoms. The outcome will be the change in total PHQ-9 score from baseline to post-intervention.
SecondaryChange in Anxiety Symptoms Assessed With the Generalized Anxiety Disorder-7Baseline and Week 4 (immediately after completion of the four-session intervention).
Anxiety symptoms will be assessed using the 7-item Generalized Anxiety Disorder scale (GAD-7). Each item is rated from 0 to 3. Item scores are summed to produce a total score ranging from 0 to 21, with higher scores indicating greater severity of anxiety symptoms. The outcome will be the change in total GAD-7 score from baseline to post-intervention.
SecondaryIntervention Completion RateFrom the first intervention session through Week 4.The intervention completion rate will be calculated as the percentage of enrolled participants who attend at least three of the four CARE-MI group sessions.
SecondaryParticipant Satisfaction With the CARE-MI InterventionWeek 4 (immediately after completion of the four-session intervention).
Acceptability will be assessed after the intervention using a participant satisfaction questionnaire. The questionnaire will evaluate participants' perceived usefulness, relevance, comprehensibility, and overall satisfaction with the CARE-MI intervention. Higher scores will indicate greater acceptability.

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT07887581

GET https://conductscience.org/api/trials/v1/NCT07887581/registered